Харьковская Медицинская Академия Последипломного Образования
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Харьковская Медицинская Академия Последипломного ОбразованияfiledCriticalХарьковская Медицинская Академия Последипломного Образования
Priority to UAU201209332UpriorityCriticalpatent/UA77695U/en
Publication of UA77695UpublicationCriticalpatent/UA77695U/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
A method for treating cognitive impairments in patients with cerebral vascular disorders by standard therapy, additionally the course of therapy is prescribed with memantin hydrochloride (Mem) by the scheme 5mg in the morning for 5 days, then 5 mg 2 times a day for 3 months.
UAU201209332U2012-07-302012-07-30method for treating cognitive impairments in patients with cerebral vascular disorders
UA77695U
(en)